JP2023552462A5 - - Google Patents
Info
- Publication number
- JP2023552462A5 JP2023552462A5 JP2023534636A JP2023534636A JP2023552462A5 JP 2023552462 A5 JP2023552462 A5 JP 2023552462A5 JP 2023534636 A JP2023534636 A JP 2023534636A JP 2023534636 A JP2023534636 A JP 2023534636A JP 2023552462 A5 JP2023552462 A5 JP 2023552462A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- polypeptide
- complex according
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122818P | 2020-12-08 | 2020-12-08 | |
| US63/122,818 | 2020-12-08 | ||
| PCT/US2021/062238 WO2022125566A1 (en) | 2020-12-08 | 2021-12-07 | Half-life extending compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552462A JP2023552462A (ja) | 2023-12-15 |
| JP2023552462A5 true JP2023552462A5 (https=) | 2024-12-12 |
Family
ID=81973740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534636A Pending JP2023552462A (ja) | 2020-12-08 | 2021-12-07 | 半減期延長組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240034814A1 (https=) |
| EP (1) | EP4259178A4 (https=) |
| JP (1) | JP2023552462A (https=) |
| KR (1) | KR20230156897A (https=) |
| CN (1) | CN117042788A (https=) |
| AU (1) | AU2021397734A1 (https=) |
| CA (1) | CA3201560A1 (https=) |
| MX (1) | MX2023006732A (https=) |
| WO (1) | WO2022125566A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| AU2021396172A1 (en) | 2020-12-09 | 2023-07-06 | Janux Therapeutics, Inc. | Compositions and methods related to tumor activated antibodies targeting psma and effector cell antigens |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| GB2641580A (en) | 2024-06-07 | 2025-12-10 | T Therapeutics Ltd | Tumour-transforming multispecific proteins |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7083784B2 (en) * | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| EP1558645B1 (en) * | 2002-11-08 | 2011-07-27 | Ablynx N.V. | Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| EP2398825B1 (en) * | 2009-02-19 | 2017-10-25 | Glaxo Group Limited | Single variable domain against serum albumin |
| EP3710480A4 (en) * | 2017-11-17 | 2021-12-15 | Nanjing Legend Biotech Co., Ltd. | SINGLE-DOMAIN ANTIBODIES AND VARIANTS OF THEM DIRECTED AGAINST PD-L1 |
| EP3807311A4 (en) * | 2018-04-24 | 2022-01-26 | National Research Council of Canada | SERUM ALBUM BINDING ANTIBODIES FOR TUNABLE HALF-LIFE OF BIOLOGICALS |
| CN113508134B (zh) * | 2019-02-22 | 2024-12-03 | 安维达生物科技公司 | 白蛋白结合抗体及其用途 |
-
2021
- 2021-12-07 JP JP2023534636A patent/JP2023552462A/ja active Pending
- 2021-12-07 CN CN202180091880.6A patent/CN117042788A/zh active Pending
- 2021-12-07 WO PCT/US2021/062238 patent/WO2022125566A1/en not_active Ceased
- 2021-12-07 CA CA3201560A patent/CA3201560A1/en active Pending
- 2021-12-07 MX MX2023006732A patent/MX2023006732A/es unknown
- 2021-12-07 US US18/256,276 patent/US20240034814A1/en active Pending
- 2021-12-07 KR KR1020237022999A patent/KR20230156897A/ko active Pending
- 2021-12-07 EP EP21904262.9A patent/EP4259178A4/en active Pending
- 2021-12-07 AU AU2021397734A patent/AU2021397734A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552462A5 (https=) | ||
| JP2022535924A5 (https=) | ||
| CN107922486B (zh) | 异源二聚体多特异性抗体形式 | |
| JP2020114210A5 (https=) | ||
| JP2023548443A5 (https=) | ||
| JP2023504914A5 (https=) | ||
| Wen et al. | Discovery and investigation of O-xylosylation in engineered proteins containing a (GGGGS) n linker | |
| JP2022512124A5 (https=) | ||
| JP2023547978A5 (https=) | ||
| JP2021159081A5 (https=) | ||
| JP2023058590A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| JP2010539921A5 (https=) | ||
| JP2013515508A5 (https=) | ||
| WO2021047559A1 (zh) | 一种断裂型内含肽、使用其的重组多肽的制备方法 | |
| JP2023552812A5 (https=) | ||
| JP2024113040A5 (https=) | ||
| JP2022538222A5 (https=) | ||
| CN116925215A (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| JP2005528914A5 (https=) | ||
| JP2021512159A5 (https=) | ||
| JP2024518539A5 (https=) | ||
| JP2022532370A5 (https=) | ||
| JP2024500335A5 (https=) | ||
| JP2025124718A5 (https=) |